title: Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban).
authors.affiliation: Hermann Heart Center, Memorial Hermann Hospital, Houston, Texas 77225-0708, USA.
authors.forename: A R
authors.initials: AR
authors.lastname: Assali
authors.forename: J
authors.initials: J
authors.lastname: Salloum
authors.forename: S
authors.initials: S
authors.lastname: Sdringola
authors.forename: A
authors.initials: A
authors.lastname: Moustapha
authors.forename: M
authors.initials: M
authors.lastname: Ghani
authors.forename: S
authors.initials: S
authors.lastname: Hale
authors.forename: G
authors.initials: G
authors.lastname: Schroth
authors.forename: K
authors.initials: K
authors.lastname: Fujise
authors.forename: H V
authors.initials: HV
authors.lastname: Anderson
authors.forename: R W
authors.initials: RW
authors.lastname: Smalling
authors.forename: O R
authors.initials: OR
authors.lastname: Rosales
mesh_terms: D000077284:Abciximab; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077144:Clopidogrel; D003327:Coronary Disease / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D000077144:Clopidogrel; D000077466:Tirofiban; D013988:Ticlopidine; D000077284:Abciximab